The QualityStocks Daily Stock List
- 4Front Ventures Corp. (FFNTF)
- American BriVision (Holding) Corporation (ABVC)
- Concrete Leveling Systems, Inc. (CLEV)
- Excellon Resources, Inc. (EXLLF)
- Harvest Oil & Gas Corp. (HRST)
- Indus Holdings, Inc. (INDXF)
- Park City Group, Inc. (PCYG)
- FISION Corp. (FSSN)
- A.M. Castle Co. (CTAM)
- Bravada Gold Corp. (BGAVF)
- Lot78, Inc. (LOTE)
- IGEN Networks Corp. (IGEN)
- Vycor Medical, Inc. (VYCO)
- Synergy CHC Corp. (SNYR)
4Front Ventures Corp. (FFNTF)
Penny Stock Hub, Green Market Report, Sweet Dispensary, Market Screener, Freedom Leaf, Investor Ideas, Morningstar, Street Insider, New Cannabis Ventures, Small Cap Power, Invest Tribune, Investing News, Midas Letter, GuruFocus, Stockhouse, and InvestorsHub reported previously on 4Front Ventures Corp. (FFNTF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
4Front Ventures Corp. is a cannabis company listed on the OTC Markets’ OTCQX. Its team can apply expertise across the value chain - from plant genetics to the cannabis retail experience. The Company has invested substantially to assemble a broad collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity offered by the increased legalization of cannabis. On July 31, 2019, Cannex and 4Front Holdings completed their business combination creating 4Front Ventures. 4Front Ventures has its corporate headquarters in Vancouver, British Columbia.
4Front Ventures owns, operates or manages six cultivation and production facilities and 11 retail facilities across eight states. Merger and acquisition discussions are ongoing in the States of California, Nevada, Connecticut, Arizona, and Ohio. The Company’s original cultivation facility in Tumwater, Washington yields 300g/sq. ft. Its new facility in Elma, Washington has demonstrated yields of 400g/ sq. ft.
Additionally, 4Front’s capabilities include Packaging & Distribution with logistics and distribution to more than 300 dispensaries in the State of Washington. 4Front Ventures’ capabilities include Extraction & Production – 20-plus brands and greater than 300 SKUs (Stock Keeping Units).
Brightleaf is 4Front's production division. In Q2 it gained control of the entire 94,000 square foot building in Elk Grove Village, Illinois, where the Company's existing production operation is housed. Mission is 4Front Ventures' retail division. In Q2 it opened a new dispensary in Rockville, Maryland. It is the third Mission dispensary in Maryland and is the result of a management and licensing relationship with the original license holder.
During Q2 2019, 4Front Ventures began planting at its new production facility in Worcester, Massachusetts, with the first of what will become perpetual harvests anticipated in Q4 2019. It began an optimization project in its Georgetown, Massachusetts production facility that should double cultivation capacity, with the resulting yields expected to begin showing up in Q4 2019 harvests.
Last week, 4Front Ventures announced that, following the closing of its merger with Cannex on July 31, 2019, it has moved fast to take Cannex's battle-tested operating capabilities, now part of 4Front's production and manufacturing division Brightleaf, and apply them to the Massachusetts marketplace.
Mr. Leo Gontmakher, 4Front Ventures Chief Operating Officer, said, "To say I am proud of my team is an understatement. Taking advantage of our pre-merger planning work, we formally took over 4Front's production and processing operations in August. By late September, we had introduced Marmas and Pebbles, two of our most successful edibles brands, to the Massachusetts' medical cannabis market. Most importantly to me, we successfully replicated the low-cost production methods we developed in Washington.”
4Front Ventures Corp. (FFNTF), closed Thursday's trading session at $0.411, off by 4.6625%, on 113,107 volume with 74 trades. The average volume for the last 3 months is 210,813 and the stock's 52-week low/high is $0.3856/$2.25.
American BriVision Corporation (ABVC)
TipRanks, Real Investment Advice, TMXmoney, Wallet Investor, 4-Traders, Morningstar, Market Screener, Stockopedia, Simply Wall St, Nasdaq, Street Insider, GlobeNewswire, Stockwatch, Stockhouse, and TradingView reported beforehand on American BriVision Corporation (ABVC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
American BriVision (Holding) Corporation is a clinical stage biopharmaceutical company based in Fremont, California. It is developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology. The Company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development. Established in 2015, American BriVision’s shares trade on the OTC Markets Group’s OTCQB.
The Company is concentrating on employing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions. These include Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center. It then concentrates on out-licensing the products to global pharmaceutical companies for pivotal Phase III studies and, eventually, generating international sales.
American BriVision released this past June positive clinical results showing efficacy and safety for its ABV-1504 Phase II (Part 2) trial, under the U.S. Food and Drug Administration (FDA) and Taiwan FDA clinical protocol code of BLI-1005-002, in major depressive disorder (MDD). The study was a randomized, double-blind, placebo-controlled, multi-center trial. Sixty adult patients with confirmed moderate-to-severe MDD were treated with PDC-1421 low dose (380 mg), PDC-1421 high dose (2 x 380 mg), or placebo for 6 weeks, three times per day. PDC-1421 is the active pharmaceutical ingredient of ABV-1504.
PDC-1421 high dose (2 x 380 mg) met the prespecified primary endpoint by demonstrating a highly significant 13.2-point reduction in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score by Intention-To-Treat (ITT) analysis, averaged over the 6-week treatment period from baseline (overall treatment effect), versus a 9.2-point decrease in the placebo group. The results support further development of PDC-1421 in MDD. The low and high doses of PDC-1421 were safe and well tolerated with no serious adverse events.
This month, American BriVision announced encouraging results from the First-in-Human Clinical Trial for Vitargus®, its investigational medical device. The results were initially reported by Dr. Andrew Chang, the principal investigator of the feasibility study, on October 11, 2019, at the Retina Subspecialty Day program of the American Academy of Ophthalmology (AAO) 2019 Annual Meeting.
A total of 13 patients were screened for the trial. Ten patients successfully completed the study. The chief goal of the study was to evaluate the safety and tolerability of a single Vitargus® dose as a vitreous substitute during vitrectomy surgery. Secondary goals included the assessment of retinal attachment and Best Corrected Visual Acuity (BCVA) after surgery.
In this study, no apparent toxicity or serious adverse events (SAEs) directly caused by Vitargus® were observed. Also, Vitargus® was well-tolerated and an effective vitreous substitute. Six SAEs were recorded from three patients, though none were deemed related to Vitargus®, according to the study’s independent data safety monitoring board.
American BriVision Corporation (ABVC), closed Thursday's trading session at $5.30, off by 1.8519%, on 800 volume with 2 trades. The average volume for the last 3 months is 1,259 and the stock's 52-week low/high is $5.11999988/$37.7999992.
Concrete Leveling Systems, Inc. (CLEV)
Awesome Penny Stocks, Insider Tracking, GuruFocus, Last10k, MarketWatch, Barchart, Business Insider, Stockopedia, Wallet Investor, MarketBeat, Dividend Investor, 4-Traders, Stockhouse, MarketWired, Capital Cube, Street Insider, Current Charts, InvestorsHub, GlobeNewswire, Stockwatch, YCharts, and Stockwatch reported earlier on Concrete Leveling Systems, Inc. (CLEV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Concrete Leveling Systems, Inc. manufactures and sells specialized equipment for end users in the concrete leveling industry. The Company provides the equipment, knowledge, as well as technical training to solve concrete settlement inquires. It offers a simple solution that is efficient and environmentally friendly at raising and re-aligning sunken concrete slabs to their original position. Incorporated in 2007, Concrete Leveling Systems is based in Canton, Ohio and lists on the OTC Markets.
The Company’s Pro X-8 concrete leveling service unit package offers a low cost, high profit alternative to traditional removal and replacement options. Using a series of 1 inch diameter holes the Pro X-8 stores, dispatches, mixes, and pumps a water based slurry that upon injection via the predrilled holes, raises and re-aligns concrete slabs back to there original position. As the slabs are being raised, the slurry continues to fill and must achieve compression before the concrete slab is raised. It is this “compression” of the pumping slurry that allows for the repaired area to be a permanent repair.
The Pro X-8 service unit package features a 16 hp Hydrapak, hopper and sub-framing that are of stainless steel construction. All machined steel parts are blasted, and powder coated for optimal corrosion protection. The design of the Pro X-8 service unit package is for user-friendliness, maintenance, and cleaning.
In March, Concrete Leveling Systems advised and updated its Shareholders this past March concerning the current direction and progress of the Company. Jericho Associates, Inc. is a Nevada corporation created as a special purpose company focusing on the casino gaming, hospitality, entertainment, and leisure time industries. Jericho entered into an agreement with Concrete Leveling Systems in March of 2017, where Jericho became the gaming and hospitality division of Concrete Leveling Systems.
Jericho acquired Vegas Winners, Inc. (VWI) and its high-profile Chief Executive Officer, Mr. Wayne Allyn Root in 2018. VWI provides sports gaming information, analysis, advice, and predictions (picks) using all available media and advertising formats.
Concrete Leveling Systems this past April, through its Casino Gaming and Hospitality Division - Jericho Associates, Inc. - updated its shareholders on Vegas Winners and the fast growth of the Sports Betting industry. Concrete Leveling Systems announced the Grand Opening of Wayne Allyn Root's VegasWINNERS.com website.
In May of this year, Concrete Leveling Systems and Jericho Associates (JAI), its gaming and hospitality division, advised its Shareholders that Jericho notified CLEV Management that with its development partner entered a comprehensive MOU (Memorandum of Understanding) and term sheet on its Southwest $190+ MIL Tribal Casino and Hotel Development project in two phases. Upon current managements review this event will fulfill the Performance Requirement of the Purchase Agreement (PA) executed between CLEV and Jericho dated March 24, 2017.
Concrete Leveling Systems, Inc. (CLEV), closed Thursday's trading session at $3.20, even for the day, on 350 volume with 4 trades. The average volume for the last 3 months is 494 and the stock's 52-week low/high is $1.00/$5.25.
Excellon Resources, Inc. (EXLLF)
StreetWise Reports, HotStocked, Resource World, Proactive Investors, Stockwatch, Stockhouse, Wallet Investor, InvestorX, Northern Miner, Geology for Investors, Trading View, and InvestorsHub reported earlier on Excellon Resources, Inc. (EXLLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Excellon Resources, Inc. is a silver mining and exploration company headquartered in Toronto, Ontario. Its 100 percent-owned Platosa Mine has been Mexico's highest-grade silver mine since production commenced in 2005. In 1996, Excellon was introduced to the La Platosa Project by Dr. Peter Megaw. Excellon Resources lists on the OTC Markets.
The Company is centered on optimizing Platosa's cost and production profile and discovering further high-grade silver and carbonate replacement deposit (CRD) mineralization on the Platosa Project. In addition, Excellon Resources is centered on epithermal silver mineralization on the 100 percent-owned 45,000 hectare Evolution Property. Moreover, it is centered on capitalizing on current market conditions by acquiring undervalued projects in the Americas.
In addition, Excellon Resources holds an option on the 164 km2 Silver City Project in Saxony, Germany. This is a high-grade epithermal silver district with 750 years of mining history and no modern exploration.
The Platosa Mine is in a safe jurisdiction with grid power. A national highway runs through the property. It is 5km north of Bermejillo, Durango State, Mexico and is 20,969 hectares.
The Evolution Property is in Miguel Auza, Zacatecas, Mexico. It is positioned 220 km from the La Platosa Mine. There is a new exploration prospect on the underexplored northern strike of the legendary Fresnillo silver trend, the most prolific silver belt in the world.
Last week, Excellon Resources announced Q3 2019 Production results. Q3 2019 Production (versus Q3 2018) include Silver Equivalent (AgEq) production of 427,131 oz (Q3 2018 – 300,766 AgEq oz); and Silver production of 257,497 oz (Q3 2018 – 171,227 oz). Production results also include Lead production of 1.3 million lb (Q3 2018 – 0.8 million lb); and Zinc production of 1.7 million lb (Q3 2018 – 1.0 million lb). Excellon Resources expects to release Q3 financial results before market open on November 6, 2019.
Excellon Resources, Inc. (EXLLF), closed Thursday's trading session at $0.7878, up 1.9806%, on 63,474 volume with 75 trades. The average volume for the last 3 months is 79,909 and the stock's 52-week low/high is $0.442999988/$1.14999997.
Harvest Oil & Gas Corp. (HRST)
Real Investment Advice, OilBlockChain.News, OTC Markets, OilandGas360, TipRanks, EnergyNow.com, MarketWatch, Nasdaq, Last10k, TradingView, Investing.com, YCharts, GuruFocus, GlobeNewswire, Barchart, Simply Wall St, Wallet Investor, Dividend Investor, Market Screener, Stockwatch, and Dividend.com reported earlier on Harvest Oil & Gas Corp. (HRST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Harvest Oil & Gas Corp. is an independent oil and natural gas company listed on the OTC Markets’ OTCQX. It engages in the development and production of oil and natural gas properties in the United States. On June 4, 2018, EV Energy Partners, L.P., successfully completed its financial restructuring and emerged from Chapter 11 of the U.S. Bankruptcy Code as Harvest Oil & Gas Corp. Established in 2006, Harvest Oil & Gas has its corporate headquarters in Houston, Texas.
Harvest Oil & Gas’ assets consist mainly of producing and non-producing properties in the Barnett Shale, the Appalachian Basin (includes the Utica Shale), Michigan, the Mid-Continent areas in Oklahoma, Texas, Kansas and Louisiana, the Permian Basin, and the Monroe Field in Northern Louisiana. The Company’s oil and natural gas properties include 545 Bcfe of estimated net proved reserves situated in Kansas, Louisiana, Michigan, New Mexico, Ohio, Oklahoma, Pennsylvania, Texas and West Virginia. Since January of this year, Harvest sold all interests in the San Juan Basin representing 157.6 Bcfe and certain interests in the Mid-Continent area representing 9.5 Bcfe.
In September, Harvest Oil & Gas announced that it completed the earlier announced sales of Barnett Shale assets and certain Mid-Continent area assets positioned in the Anadarko Basin and SCOOP/STACK. Furthermore, the Company plans to enter into a new credit facility and is initiating a strategic review process. It is undertaking a review of strategic alternatives and has engaged Intrepid Partners, LLC to assist it in the process.
The comprehensive review will include, but not be limited to, the potential divestiture of additional assets or all of Harvest’s remaining assets and a potential sale or merger of the Company. Harvest Oil & Gas will also be reviewing options to decrease its overall cost structure to more closely align with the pro forma asset base after the Barnett and Mid-Continent divestitures.
Harvest Oil & Gas Corp. (HRST), closed Thursday's trading session at $5.45, up 3.8095%, on 6,774 volume with 41 trades. The average volume for the last 3 months is 3,333 and the stock's 52-week low/high is $4.00/$23.209999.
Indus Holdings, Inc. (INDXF)
NIC Investors, Market Wire News, Penny Stock Hub, New Cannabis Ventures, Stockwatch, Investing.com, Dividend.com, mg Magazine, GlobeNewswire, PetaCrunch, Morningstar, CBD Gummies World, Stockhouse, News Scanner, TradingView, and Wallet Investor reported earlier on Indus Holdings, Inc. (INDXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Indus Holdings, Inc. is a vertically integrated cannabis company listed on the OTC Markets Group’s OTCQX. It has advanced production capabilities, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Hospitality veteran Mr. Robert Weakley founded the Company. Established in 2014, Indus Holdings has its corporate office in Salinas, California.
The Company offers services supporting every step of the supply chain and also offers a wide-ranging portfolio of award-winning brands. These brands include House Weed, The Original Pot Co., MOON, Acme, Beboe, Dixie Elixirs & Edibles, and Orchid Essentials. Indus Distribution is a division of Indus Holdings, Inc. Indus Distribution is a top distributor of cannabis products, servicing a broad portfolio of brands and licensed retailers.
Indus’ leadership team consists of hospitality, culinary, law enforcement, technology, finance, sales, and marketing veterans. The Company’s dedication is to transparency, working within the regulations of a growing market, and creating partnerships with community, State, and industry leaders who share Indus’ vision. Indus is creating products that emphasize consumer safety while advancing changing perceptions of cannabis use.
In May of this year, Indus Holdings announced that it signed a definitive agreement to acquire the assets of W The Brand (W Vapes), a multi-state manufacturer and distributor of cannabis concentrates, cartridges, and disposable pens, in a cash and stock transaction. This transaction solidifies Indus’ position as a market leader and leading force in the cannabis industry via expansion of its operations beyond the State of California into the cannabis-friendly States of Nevada and Oregon.
Last month, Indus Holdings announced that the OTC Markets Group, Inc. approved the trading of Indus Holdings, Inc. shares on the OTCQX® Best Market, the premium market tier of OTC Markets Group. Shares began trading at the opening of the market on September 17, 2019 under the symbol “INDXF.”
Indus Holdings’ Co-Founder and Chief Executive Officer, Mr. Robert Weakley, said, “We are very excited to be cross-trading on both the OTCQX and CSE. The OTCQX approval is a tremendous milestone, as it makes our shares accessible to an even broader range of institutional and retail investors, aligning with our goal of increasing the liquidity and convenience of trading Indus shares within the U.S.”
Indus Holdings, Inc. (INDXF), closed Thursday's trading session at $1.7273, up 6.6235%, on 32,950 volume with 27 trades. The average volume for the last 3 months is 3,181 and the stock's 52-week low/high is $1.39999997/$11.0968999.
Park City Group, Inc. (PCYG)
Zacks, Nasdaq, Stocks Equity, AI Stock Finder, Infront Analytics, EarningsCast, Market Screener, Investing.com, Last10k, Proactive Investors, Stockhouse, TradingView, GlobeNewswire, TMXmoney, Seeking Alpha, Morningstar, InvestorsHub, and Simply Wall St reported beforehand on Park City Group, Inc. (PCYG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Park City Group, Inc. is a Software-as-a-Service (SaaS) provider that brings visibility to the consumer goods supply chain through its wholly-owned ReposiTrak, Inc. subsidiary. ReposiTrak is The Speed Retail Platform, with three product families. These are Compliance & Risk Management, Supply Chain Solutions, and MarketPlace Sourcing and B2B Commerce. The Company chiefly serves multi-store retail chains, wholesalers and distributors, and suppliers. Park City Group is based in Murray, Utah. The Company lists on the NasdaqCM.
For over 18 years, Park City Group has been helping customers with B2B Vendor Connections, Item & Cost Maintenance, Scan-based Trading, Invoicing from POS or Delivery, Vendor Scorecarding, Reporting & Analytics, Out-Of-Stock & Waste Reporting, and Forecasting & Ordering (Store-level & DC). ReposiTrak was originally co-founded with Leavitt Partners, led by Mr. Michael Leavitt, former Secretary of Health & Human Services, to address the expected rise in regulatory requirements associated with the Food Safety Modernization Act of 2011 (FSMA).
In essence, ReposiTrak is a compliance, supply chain, and e-commerce platform. ReposiTrak partners with retailers, wholesalers, and their suppliers, to increase sales, control risk, and improve supply chain efficiencies. The Company’s platform is the only completely integrated sourcing, compliance, and supplier & item management platform on the market. All of Park City Group’s capabilities are accessible via a cloud-based portal that comprises the ReposiTrak Speed Retail Platform.
The ReposiTrak platform provides retailers and suppliers with a strong solution suite to help enhance operational control and boost sales. This is while enabling them to protect their brands, reduce risk and remain in compliance with regulatory requirements.
Earlier in October, ReposiTrak announced that The Orchards Gourmet Nuts, Candies and Gifts, LLC (Wrens, Georgia) selected the ReposiTrak Compliance & Risk Management Solution to automate document compliance to address food safety regulations and support its food safety quality certification efforts. The Orchards provides gourmet nuts, candies, confections, snacks and gifts to retailers and wholesalers. The Orchards adopted ReposiTrak because it needed an automated system for handling food safety government regulations and meeting Safe Quality Food (SQF) certification requirements.
Last week, ReposiTrak reported that 80 percent of the 200 vendors utilizing its OOS Management Solution saw an average decrease of 39 percent in out-of-stocks in less than three months. Those decreases occurred across nine different retailers with greater than 12,175 stores in the categories of grocery, dairy, bakery, as well as general merchandise.
Park City Group, Inc. (PCYG), closed Thursday's trading session at $5.45, off by 2.3297%, on 7,967 volume with 94 trades. The average volume for the last 3 months is 44,738 and the stock's 52-week low/high is $4.76000022/$9.25.
FISION Corp. (FSSN)
NetworkNewsWire, Penny Stock Tweets, Stockhouse, InvestorsHub, InvestorPoint, The Street, Wallet Investor, Market Screener, OTC Markets, Stockwatch, Dividend Investor, Investing, YCharts, Barchart, TradingView, MarketWatch, Business Wire, GuruFocus, and Capital Market Access reported earlier on FISION Corp. (FSSN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
FISION Corp. is a cloud-based digital asset management and marketing automation company. It serves enterprise clients in the healthcare, hospitality, financial/insurance, software, and technology industries. The Company is an effective sales enablement and marketing asset management tool. Established in 2011 and OTCQB-listed, FISION is based in Minneapolis, Minnesota.
FISION maximizes the brand potential of every sales interaction. The Company’s advanced, proprietary technology specializes in managing customers’ brand and marketing content. This enables marketing and sales people to quickly and easily create compelling, personalized, on-brand communications that increase revenue and profits.
FISION equips marketing and sales teams with a wide-ranging set of enablement capabilities built to solve distributed marketing challenges. FISION’s solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. FISION’s centralized, cloud-based library supports manifold different file types. It gives a client complete control over how company assets are stored, retrieved, and used.
FISION completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-based) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology. Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, and sales enablement software. Volerro’s ReVu.Me cloud app allows team members to work on the same document in real-time with integrated chat and voice conferencing.
In August 2018, FISION announced a merger agreement with Continuity Logic LLC. FISION's "front of the house" sales and marketing solution is complemented by Continuity Logic's "back of the house" enterprise integration & user-friendly application interface. This agreement in 2018 allowed both companies to immediately take advantage of each others customer base and sales pipeline, with no current overlapping of clients.
In October 2018, FISION announced it was named the #1 software company in Minnesota by Twin Cities Business (TBC) magazine. FISION is the category winner in the publication’s 2018 Best of Business Reader’s Choice Awards. FISION currently has greater than 65,000 users across 21 countries.
FISION Corp. (FSSN), closed Thursday's trading session at $0.018, up 20.00%, on 58,000 volume with 3 trades. The average volume for the last 3 months is 68,828 and the stock's 52-week low/high is $0.0125/$0.189999997.
A.M. Castle & Co. (CTAM)
Tip Ranks, Stockhouse, GuruFocus, Simply Wall St, Barchart, YCharts, Wallet Investor, StockTwits, Jet Life Penny Stocks, Stockwolf, Penny Stock Hub, MarketWatch, The Street, Morningstar, InvestorsHub, TradingView, Stockwatch, and Whale Wisdom reported earlier on A.M. Castle & Co. (CTAM), and we also report on the Company, here at the QualityStocks Daily Newsletter.
A.M. Castle & Co., together with its subsidiaries, operates as a specialty metals distribution company in the United States, Canada, Mexico, and internationally. As of March 13, 2018, it operated 22 metals service centers. A.M. Castle distributes engineered specialty grades and alloys of metals. Additionally, the Company offers specialized processing services. OTCQX-listed, A.M. Castle has its head office in Oak Brook, Illinois.
The Company also performs varied specialized fabrications for its customers through subcontractors, which thermally process, turn, polish, and straighten alloy and carbon bars. A. M. Castle primarily serves Fortune 500 companies, and medium and smaller sized firms operating in the producer durable equipment, aerospace, heavy industrial equipment, industrial goods, construction equipment, and retail sectors.
The Company works with worldwide original equipment manufacturers (OEMs) to better serve their multi-location production requirements and delivery needs. Also, A.M. Castle help the thousands of machine shops that service the OEMs or have their own niche end market.
A.M. Castle specializes in the distribution of alloy and stainless steels; nickel alloys; aluminum and carbon. The Company’s products include alloy, aluminum, nickel, stainless steel, carbon, and titanium in plate, sheet, extrusions, and round bar. Furthermore, its products include hexagon bar, square and flat bar, tubing, and coil forms.
A.M. Castle’s H-A Industries is a state-of-the art heat-treat and bar processing facility. H-A Industries provides a wide spectrum of thermal treating and finishing services. The Company also offers a complete range of value-added processing services for plate, sheet, tubing and bar products from locations throughout its network.
Concerning Oil & Gas, A.M. Castle’s metallurgical and supply chain expertise helps oil and gas customers meet unique specifications with stable supplies. Regarding Machine Shops, the Company can help a business operate efficiently and competitively. It accomplishes this through local facilities, first-rate inventory, as well as advanced processing.
Pertaining to Aerospace, A.M. Castle helps aerospace and defense companies navigate complex requirements, schedules, and subcontractor networks. Regarding Industrial, the Company customizes supply plans to customers across industrial sectors - from heavy equipment to semiconductors.
Recently, A. M. Castle & Co. announced that it qualified to trade on the OTCQX® Best Market after formerly trading on the OTCQB® Venture Market. The OTCQX® Best Market is reserved for companies meeting high financial standards, adhering to best corporate governance and compliance practices and requires a professional third-party sponsor introduction.
Chairman and Chief Executive Officer, Mr. Steve Scheinkman of A. M. Castle & Co. said, “Upgrading to OTCQX evidences A. M. Castle’s successful transformation since completing our financial restructuring in 2017. Moreover, we have now demonstrated an ability to generate positive EBITDA in excess of cash interest and are continuing to focus on improving the profitability of our core operations and executing strategic growth initiatives.”
A.M. Castle & Co. (CTAM), closed Thursday's trading session at $2.50, up 58.2278%, on 400 volume with 4 trades. The average volume for the last 3 months is 200 and the stock's 52-week low/high is $1.58000004/$7.00.
Bravada Gold Corp. (BGAVF)
Gold Investment Letter, Penny Stock Hub, 4-Traders, NorthernVertex, Stockhouse, Morningstar, Cambridge House International, The Street, Dividend Investor, The Prospector News, and Real Pennies reported on Bravada Gold Corp. (BGAVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties include a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development. Bravada Gold is based in Vancouver, British Columbia and the Company lists on the OTC Markets Group’s OTCQB.
Bravada Gold retains residual working or royalty interests. The Company explores for precious metals in well-established gold trends in one of the world’s best gold jurisdictions.
At present, five of Bravada’s Nevada properties are being backed by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.
Regarding its Wind Mountain project, the Company’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization under the existing disseminated resource at Wind Mountain. Pertaining to the SF property, Bravada Gold plans to drill-test for high-grade “Carlin-type” gold mineralization at the property.
Concerning the North Lone Mountain and South Lone Mountain projects, plans have not been finalized for Bravada Gold’s two claim groups. However, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada Gold’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada will retain a royalty on base and precious metals.
Bravada Gold received earlier this year, subject to posting a reclamation bond, approval of its drilling permit from the U.S. Forest Service for its Quito Gold property. The permit allows four sites to be drilled at the Quito Extension target in 2018. Numerous holes can be drilled from these sites. The Quito Property is situated along the Austin Gold trend in central Nevada.
Bravada Gold, by way of its wholly-owned U.S. subsidiary Bravo Alaska, Inc., and Yamana Gold, Inc., through its wholly-owned U.S. subsidiary Meridian Minerals Corp. (collectively Yamana), have agreed to amend the earn-in agreement for the Quito Property.
This amendment will remove a "Claw-back" provision, which allowed Yamana Gold to re-acquire a 51 percent ownership in Quito after earn-in by Bravada Gold of a 70 percent working interest (WI) in the property with all other terms remaining constant. As consideration for the amendment, Yamana Gold receives 1,000,000 common shares in Bravada Gold and warrants to buy 1,000,000 common shares at CDN$0.15 for a period of three years.
Recently, Bravada Gold announced that the earlier announced $480,000 non-brokered private placement has been oversubscribed. The Company will now issue 6,584,000 units in a non-brokered private placement at a price of $0.08 per Unit for gross proceeds of $526,720. Net proceeds from the private placement will be used for property maintenance fees, permitting fees and associated ancillary costs, and accounts payable and for working capital.
Bravada Gold Corp. (BGAVF), closed Thursday's trading session at $0.0571, up 24.6453%, on 15,223 volume with 3 trades. The average volume for the last 3 months is 54,003 and the stock's 52-week low/high is $0.039/$0.154200002.
Lot78, Inc. (LOTE)
Promotion Stock Secrets, Street Register, OTC Markets, Emerging Growth, Aim High Profits, Insider Financial, Penny Stock Tweets, Stockwatch, Penny Stock Dream, Hotstocked, and Predict Wall Street reported on Lot78, Inc. (LOTE), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Lot78, Inc. designs, markets, distributes and sells apparel under the Lot78 brand name. It operates in three segments: Wholesale, Consumer Direct, and Core Services. Ollie Amhurst is the Founder and Creative Director of the Company. From the start, the business strategy was to build Lot78 into a men’s and women’s ready to wear line. Lot78 has its head office in London, England.
The Company was incorporated in Nevada on June 27, 2008. On March 14, 2011, it filed a Certificate of Amendment with the Secretary of State of Nevada changing the name of the Company to "Bold Energy, Inc."
On November 12, 2012, the Company, then under the name Bold Energy, entered into a Share Exchange Agreement with Anio Limited a limited liability company formed under the laws of the United Kingdom (Anio Ltd.) that conducts its main line of business under the name Lot78, Inc., the shareholders of Anio Ltd., and the controlling stockholders of the Company.
On January 31, 2013, it changed names to Lot78, Inc. On July 15, 2016, the Company entered into a Letter of Intent (LOI) to merge with Compound Holdings, LLC, a Connecticut limited liability company. Then, on July 18, 2016, the Company and Compound Holdings LLC entered into a definitive Agreement and Plan of Merger. With this plan of merger, upon closing, its intention is to change its name to Compound Holdings, Inc.
Lot78 offers a collection of men's and women's ready to wear line that includes leather jackets, T-shirts, sweats, knitwear, accessories, jeans, chinos, and wool coats. The Company sells its products to department stores, specialty retailers, and boutiques. In addition, it sells its products via lot78.com.
In October of 2017, Lot78 announced that it was scheduled to acquire a 2.5 percent equity stake in Garage Juice Bar, LLC also known as Juice Bar Electric Vehicle Charging Stations. Lot78 stated that this investment aligns with the Company’s mission to provide value to shareholders via the acquisition of investments, which show potential to be scaled regionally and/or nationally or investments that drive outsized returns.
Lot78, Inc. (LOTE), closed Thursday's trading session at $0.007012, up 27.4909%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 82,522 and the stock's 52-week low/high is $0.002499999/$0.0269.
IGEN Networks Corp. (IGEN)
NetworkNewsWire.com, MarketWatch, InvestorsHub, Marketwired, OTC Markets, Information Vine, Business Insider, Stock Press Daily, The Street, and Barchart reported on IGEN Networks Corp. (IGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
IGEN Networks Corp. is a foremost innovator of cloud-based and Internet of Things (IoT) automotive solutions for the protection and management of mobile assets. The Company provides peace-of-mind to automotive consumers and their families via direct access to IoT cloud-based services, which include Stolen Vehicle Protection, Real-time updates on asset health and Driver Behavior. OTCQB-listed and incorporated in 2006, IGEN Networks has its head office in Murrieta, California.
The Company provides vehicle tracking and recovery solutions to the automotive dealership industries in the U.S. IGEN Networks serves the automobile industry through vehicle security services, lot management services, and driver behavior services.
IGEN Networks enables automotive dealer channels to provide new products, create additional revenue streams, as well as keep their customers. The Company provides peace-of-mind to consumers through providing direct access to vehicle status and driver behavior. The Company also enables insurance companies to decrease their rating errors through offering consumers discounted premiums in return for access to vehicle and driver behavior data.
IGEN Networks previously announced the launch of Medallion GPS™. Medallion GPS™ is a new, easily installed, direct-to-consumer solution. It combines vehicle agnostic hardware with cloud based smartphone software. This system provides automotive aftermarket customers with a new standard in stolen vehicle recovery support, vehicle systems alerts, driver behavior monitoring and GPS tracking capabilities, in addition to other features.
Recently, IGEN Networks announced the filing of its Q3 2017 financial results. The Company increased year-to-date Revenue 26 percent to 1.04 million, boosted by growing adoption of its mobile asset tracking platforms. It grew the subscriber base 264 percent year-over-year, to over 31,000 assets at September 30, 2017.
IGEN increased deferred revenue 146 percent, to $182,000. The Company increased gross margin to 39.2 percent through the first nine months, versus 36.8 percent in the previous year period. It reported a Net Loss of $662,000 year-to-date, excluding stock based compensation expenses, versus $551,000 in the previous year nine-month period.
IGEN Networks Corp. (IGEN), closed Thursday's trading session at $0.0378, up 50.5976%, on 460,206 volume with 16 trades. The average volume for the last 3 months is 33,863 and the stock's 52-week low/high is $0.020999999/$0.087499998.
Vycor Medical, Inc. (VYCO)
PennyStockScholar, FeedBlitz, OTCtipReporter, and Wall Street Resources reported earlier on Vycor Medical, Inc. (VYCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Vycor Medical, Inc. is a provider of distinct and first-class surgical and therapeutic solutions. The Company operates two business units - Vycor Medical and NovaVision. Both of these business units adopt a minimally or non-invasive approach. Vycor Medical has U.S. Food and Drug Administration (FDA) 510(k) clearance for brain and spine surgeries and regulatory approvals for brain in Australia, Brazil, Canada, China, Europe (EU – Class III), Korea, Japan, Russia, and Taiwan. Vycor Medical is based in Boca Raton, Florida.
The Company’s NovaVision provides non-invasive, computer-based rehabilitation targeted at a substantial and largely un-addressed market of people who have lost their sight because of stroke or brain injury. The NovaVision business unit develops and provides science-driven neurostimulation therapy and other medical technologies. This helps improve and partially restore sight in patients with neurological vision impairments.
Vycor Medical’s ViewSite™ Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices. These have the potential for quicker, safer, and also more economical brain surgeries, as well as faster patient discharge.
The design of VBAS is to optimize neurosurgical site access and reduce patient risk. In addition, the design of VBAS is to expedite recovery and add tangible value to the professional medical community.
The Company’s proprietary Visual Restoration Therapy® (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury (TBI), or other acquired brain injuries. VRT is the only FDA 510K cleared medical device in the United States targeted at the restoration of vision for neurologically induced vision loss.
Vycor Medical has developed NeuroEyeCoach™. This is a therapy that is highly complementary to VRT™. NeuroEyeCoach™ is a compensation therapy registered in the United States as a Class I 510(k) exempt device. The design of NeuroEyeCoach is to improve a patient's ability to scan their environment more efficiently. NeuroEyeCoach is NovaVision's eye movement compensation therapy for patients who have suffered a cerebral visual field disorder due to a stroke or brain injury.
During 2017, the US patent office (USPTO) issued/allowed four patents. These are all directed to the integration of neuro-navigation systems with Vycor Medical's VBAS retractor system.
The patents complement and strengthen the Company’s existing patent portfolio. This is especially in relation to Vycor’s continuing emphasis to more fully integrate its VBAS product range with neuro-navigation systems without sacrificing the surgeon's ability to visually inspect the surrounding tissue as the devices undergo insertion.
Vycor Medical, Inc. (VYCO), closed Thursday's trading session at $0.1597, up 16.1455%, on 10,281 volume with 4 trades. The average volume for the last 3 months is 5,026 and the stock's 52-week low/high is $0.032099999/$0.239800006.
Synergy CHC Corp. (SNYR)
SmallCapVoice, MarketWatch, OTC Markets, and TradingView reported earlier on Synergy CHC Corp. (SNYR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Synergy CHC Corp. is a consumer health care company listed on the OTC Markets. It is in the process of building a portfolio of best-in-class consumer product brands. The Company’s strategy is to increase its portfolio organically and through further acquisition. Established in 2012, Synergy CHC is headquartered in Westbrook, Maine.
The Company sells its products mainly in North American retail locations. Its diversified portfolio includes Flat Tummy Tea™, FOCUSFactor™, Neuragen™, and Hand MD®. Flat Tummy Tea™ is an innovatively formulated two-step herbal detox tea. It works to naturally help speed up metabolism, boost energy, and reduce bloating to flatten one’s stomach/tummy.
FOCUSFactor is a nutritional supplement. It includes a proprietary blend of brain supporting vitamins, minerals, antioxidants, and other nutrients.
Neuragen® is a topical product. It works directly at the site of the pain contrasted with oral products. Neuragen® reduces the spontaneous firing of damaged peripheral nerves.
Also, Synergy CHC’s Hand MD® is the world's first anti-aging skincare line formulated specifically for the hands. Synergy CHC has also launched its newest brand, Sneaky Vaunt®.
Synergy CHC officially launched The Synergy Effect, its ROI (Return on Investment) innovation engine and online marketing platform. The Synergy Effect was built to boost online revenue growth for all of the Company’s brands.
This past June, Synergy CHC announced that it entered into, and at the same time closed on, an Asset Purchase Agreement with Per-fekt Beauty Holdings, LLC and CDG Holdings, LLC, which owns 92.3 percent of the issued and outstanding equity interests of Per-fekt Beauty. Per-fekt Beauty engages in developing and selling skincare and cosmetics products under the brand Per-fekt.
With this Purchase Agreement, Synergy CHC purchased all of Per-fekt Beauty's assets and assumed certain of its liabilities for a purchase price of $709,988.34. As additional consideration, it will pay quarterly royalties equal to 5 percent of Net Sales for 10 years following the closing date.
Synergy CHC Corp. (SNYR), closed Thursday's trading session at $0.169, up 30.00%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 1,824 and the stock's 52-week low/high is $0.101000003/$0.289999991.
The QualityStocks Company Corner
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- CloudCommerce (OTCQB: CLWD)
- Endonovo Therapeutics Inc. (ENDV)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Marijuana Company of America (OTCQB: MCOA)
- Predictive Oncology (NASDAQ: POAI)
- Sharing Services Global Corporation (SHRG)
- SRAX Inc. (NASDAQ: SRAX)
- Sugarmade, Inc. (SGMD)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- VPR Brands, LP (VPRB)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a publication from CBDWire, examining how young Bailey Rankmore, who suffers from Lennox-Gastaut syndrome, a particularly nasty form of epilepsy that sees him having up to 100 seizures on a daily basis. He is the latest in an increasing number of people in the UK who have used CBD to help manage severe conditions.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $1.22, up 5.1633%, on 212,872 volume with 209 trades. The average volume for the last 3 months is 248,257 and the stock's 52-week low/high is $0.843599975/$5.20499992.
- Parents of Epileptic Teen Plead For Easier Access to CBD Prescriptions
- CBD is Quickly Becoming the Most Searched Topic on Google
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Posts Q4 and Full Year Financial Results, Hosts Conference Call
CloudCommerce (OTCQB: CLWD)
CloudCommerce (OTCQB: CLWD) president Andrew Van Noy recently discussed the company’s accomplishments to date and its strategy moving forward in a NetworkNewsAudio (NNA) interview with Stuart Smith of NetworkNewsWire (http://nnw.fm/Ik6Vo). To view the full article, visit http://nnw.fm/jaH3H.
CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.
SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.
Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.
Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.
However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.
In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.
THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.
BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.
HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.
HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.
Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.
Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.
Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.
Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.
Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.
CloudCommerce (OTCQB: CLWD), closed Thursday's trading session at $0.0027, up 3.4483%, on 6,261,000 volume with 15 trades. The average volume for the last 3 months is 1,116,665 and the stock's 52-week low/high is $0.0026/$0.0228.
- CloudCommerce Inc. (CLWD) President Discusses Future Strategy in NetworkNewsAudio Interview
- CloudCommerce Inc. (CLWD) Brings Micro-Targeting to Brand Distributers, Marketers
- CloudCommerce Inc. (CLWD) Helping Businesses Find Target Customer Groups with SWARM
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement with respect to a proposed a reverse stock split of its common stock at a ratio of between 1 for 100 and 1-for-1,000.
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s targeted pulsed electromagnetic field (tPEMF) transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Steven C. Levin, M.D., Scientific Advisory Board Member
Dr. Steven C. Levin is the regional medical director at Johns Hopkins School of Medicine and medical director at Howard County General Hospital in Columbia, Maryland. Additionally, he is an assistant professor at Johns Hopkins School of Medicine, Department of Anesthesiology. Dr. Levin is currently the co-chair of the Opioid Stewardship Clinical Community as well as a clinical design team leader of the Musculoskeletal Center in the Johns Hopkins Health System. Additionally, Dr. Levin has previously served on the medical school facility at Yale University and at University of Pittsburgh Medical Center. Dr. Levin received his undergraduate degree from University of Pennsylvania and medical degree at the University of Pittsburgh. He completed his residency and fellowship at the University of Pittsburgh Medical Center. His membership in professional and scientific societies has included the American Society of Anesthesiology, American Pain Society, American Society of Regional Anesthesia, Society in Anesthesia and International Association for the Study of Pain.
Peter Novak, M.D., Ph.D., Scientific Advisory Board Member
Dr. Peter Novak is the director of the Autonomic Laboratory at the Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts. He is a board-certified neurologist and a board-certified autonomic specialist. He is a member of the American Academy of Neurology, American Autonomic Society and the Autonomic Board of United Council for Neurologic Subspecialties. Dr. Novak graduated from medical school in Bratislava, Slovakia, and completed his neurology residency at Ohio State University. He also completed postdoctoral studies focusing on cardiovascular and autonomic research at Charles University (Prague) the University of Montreal, McGill University (Montreal) and the Mayo Clinic. He has special interests in autoimmune, small fiber and autonomic neuropathies, autoimmune, postural orthostatic tachycardia syndrome and multiple system atrophy. He has written over 70 papers and presented at numerous conferences.
Geoffrey Abrams, M.D., Scientific Advisory Board Member
Dr. Geoffrey Abrams is an assistant professor of orthopedic surgery at the Stanford University School of Medicine and the director of sports medicine for Stanford’s varsity athletes. He specializes in orthopedic sports medicine and arthroscopy of the shoulder, knee and elbow as well as upper extremity joint replacement surgery. Dr. Abrams is a member of the American Academy of Orthopedic Surgeons (AAOS) and the American Orthopedic Society for Sports Medicine (AOSSM), among others, and currently serves as assistant team physician for the NFL’s San Francisco 49ers as well as head team physician for a number of Stanford University varsity athletic teams. He is actively involved in research focusing on the role of inflammatory mediators, and microRNA in particular, on cartilage and tendon damage. Dr. Abrams received his undergraduate degree from Stanford University and his doctorate of medicine from the University of California – San Diego. He completed his residency in orthopedic surgery at Stanford University and went on to receive additional training in Orthopedic Sports Medicine and Shoulder Surgery at Rush University Medical Center in Chicago, Illinois. Dr. Abrams has authored or co-authored over 60 peer-reviewed scientific articles, over 20 book chapters, has presented original research at numerous national and international scientific meetings, and serves as a reviewer for numerous sports medicine scientific journals.
Dr. William Li, Scientific Advisory Board Member
Dr. William Li is CEO and co-founder of the Angiogenesis Foundation. He trained in the lab of Dr. Judah Folkman, pioneer of the angiogenesis field, and has been actively engaged in angiogenesis research and clinical development for 30 years. Under Dr. Li’s leadership, the foundation has developed a unique social enterprise model based on value-creating collaborations with leading biopharmaceutical and medical device companies. Dr. Li is actively engaged in identifying unmet needs in the healthcare space for which clinical and cost-effective technology can offer beneficial solutions. He is a graduate of Harvard, and completed his medical residency training at Massachusetts General Hospital in Boston. He serves as advisor and consultant to leading global public and private companies.
Mykol Larvie, Scientific Advisory Board Member
Recipient of three Harvard Medical Student Teaching awards in Principal Clinic Experience, Mykol Larvie is currently a radiologist in the Cleveland Clinic’s Divisions of Nuclear Medicine and Neuroradiology as well as the director of Functional and Molecular Neuroimaging. With a completed internship in the Department of Medicine as well residency in the Department of Radiology and fellowship in the Division of Neuroradiology at the Massachusetts General Hospital, Dr. Larvie specializes in PET examinations of the brain performed typically for the evaluation of neurodegenerative disease, seizure and tumor. He delivers didactic lectures and case conferences to residents and fellows six times per year and serves as a mentor and advisor to medical students, residents and fellows.
Nathan L. Guerette, Scientific Advisory Board Member
Nathan L. Guerette is the director and president of the Female Pelvic Medicine Institute of Virginia; an associate clinical professor in the division of Urogynecology and Pelvic Reconstructive Surgery at the Medical College of Virginia; a full clinical professor in Urogynecology and Pelvic Reconstructive Surgery at the Riverside Regional Medical Center; and the Robotic Surgery director at the Chippenham and Johnston Willis Medical Center. With a completed fellowship in urogynecology and pelvic reconstructive surgery at the Cleveland Clinic Foundation, Dr. Guerette has won seven awards in the medical and humanitarian departments. He has made nine media appearances, some of which were on PBS and NBC News. He has three board certiﬁcations and has ran a surgical mission trip to Trujillo, Peru, through Bon Secours.
Dr. Ashling O’Connor, Scientific Advisory Board Member
Currently a surgeon at the Comprehensive Breast Health Center of the Lahey Medical Center, Dr. O’Connor has won seven awards in the surgical department. She has completed a surgical internship at the Mater Misericordiae Hospital in Dublin as well as a breast surgery fellowship at the University of Massachusetts Interdisciplinary Breast Fellowship. She mentors medical students and surgical residents both in the operating room and in a clinical setting and enjoys biking and triathlons as well as trail and marathon running. She is certiﬁed in the Hidden Scar technique in breast surgery as well as in the advanced cardiac life support and is a member of the Protocol Review Committee Umass Memorial Medical Center, the New England Surgical Society and the American College of Surgeons.
Samir Awad, Scientific Advisory Board Member
Samir Awad has worked for the Department of Veterans Affairs since 2000. He has served as the operative care line associate executive, chief of general surgery, and medical director of the Surgical Intensive Care Unit at the MEDVAMC. Dr. Awad’s areas of specialty include liver, pancreas, and acute care surgery, as well as minimally invasive surgical procedures. He is a member of the Association for Academic Surgeons, the Society of University Surgeons, the American College of Surgeons, the Surgical Infection Society, and the Society for Critical Care Medicine. Dr. Awad has authored more than 100 peer-reviewed and invited publications and is the recipient of numerous awards for surgical and research achievements. Dr. Awad is certified by the American Board of Surgery and Surgical Critical Care.
Endonovo Therapeutics Inc. (ENDV), closed Thursday's trading session at $0.00599, off by 17.3793%, on 40,841,432 volume with 359 trades. The average volume for the last 3 months is 3,906,256 and the stock's 52-week low/high is $0.0035/$0.043999999.
- Endonovo Therapeutics Announces Reverse Stock Split
- Endonovo Therapeutics Inc.’s (ENDV) SofPulse® Receives Positive Review in Video Testimonial
- Endonovo Therapeutics Inc. (ENDV) Appoints Strategic Advisor to the CEO to Explore Growth Opportunities
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
The recent climb in the stock price of Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)looks to be the harbinger of a bright future for the innovative global developer of drug-delivery platforms. After the FDA announced it had authorized the marketing of products through the modified-risk, tobacco-product (MRTP) pathway, LXRP stock jumped 24 percent, up to $0.72 from $0.58 on the OTC Markets.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.55, off by 4.7784%, on 54,851 volume with 52 trades. The average volume for the last 3 months is 87,707 and the stock's 52-week low/high is $0.399800002/$1.70000004.
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Stock Jumps After FDA Announcement on Smokeless Tobacco Products
- Illinois Hemp Farmer Shares Experience of Going Back to Farming Basics
- Lexaria Equity Financing and Corporate Strategy Update
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America (OTCQB: MCOA) was highlighted today in a publication from Financialnewsmedia.com, examining how the U.S. and China are opponents in many categories today and years to come. In some of these interactions there are no winners or losers, however, the U.S. is the clear winner in the global hemp cultivation market. Hemp has more uses that most people would expect from fabric to medicinal uses, but it is the rise of the CBD market that makes this an important ‘win’.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Thursday's trading session at $0.1865, off by 5.998%, on 235,740 volume with 127 trades. The average volume for the last 3 months is 306,049 and the stock's 52-week low/high is $0.023/$2.10599994.
- U.S. Cannabinoid Market Including Hemp Now Projected to Reach $44.8 billion by 2024
- North Carolina Senate Reaches Compromise on Hemp Law
- Marijuana Company Of America Announces CBD Beverage Supply Pact With MCTC Holdings
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announces that its Helomics subsidiary has begun to sequence tumor cases from its UPMC Magee collaboration (http://nnw.fm/4uKXL). Also today, the company was highlighted in a publication from GlobeNewswire, examining how POAI has announced the availability of a broadcast titled, “Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/8zJx5. To read the full editorial, visit: http://nnw.fm/j6Orz.
Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Predictive Oncology (POAI), closed Thursday's trading session at $3.56, off by 8.8348%, on 11,623 volume with 80 trades. The average volume for the last 3 months is 7,635 and the stock's 52-week low/high is $3.31999993/$8.50.
- Predictive Oncology Reaches First Milestone in Building AI-driven Predictive Models of Ovarian Cancer
- Predictive Oncology (NASDAQ: POAI) Featured in Broadcast on Big Data, AI’s Potential to Fight Cancer
- Predictive Oncology Inc.’s (NASDAQ: POAI) Valuable Database Offers Hope to Cancer Patients of Today and Tomorrow
Sharing Services Global Corporation (SHRG)
Diversified holdings company Sharing Services Global Corporation (OTCQB: SHRG), together with its wholly owned Elevacity Global subsidiary, provides a unique line of health and wellness products for its independent sales force. To view the full article, visit http://nnw.fm/D7qCt.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.1241, off by 11.3571%, on 62,525 volume with 14 trades. The average volume for the last 3 months is 34,288 and the stock's 52-week low/high is $0.090000003/$0.3944.
- Sharing Services Inc. (SHRG) Subsidiary Designs Products to Elevate Consumers’ Health, Happiness
- Sharing Services Global Corporation (SHRG) Reports Record Revenues, Continues Impressive Sales Momentum
- Sharing Services Global Corporation’s (SHRG) Consumer-Driven Approach Positions it for Longevity in Direct Sales Industry
SRAX Inc. (NASDAQ: SRAX)
Digital marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX) is staying a step ahead of the competition as new privacy laws come into play in California. To view the full article, visit http://nnw.fm/8tYZs.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Thursday's trading session at $1.71, up 3.6364%, on 63,459 volume with 318 trades. The average volume for the last 3 months is 95,356 and the stock's 52-week low/high is $1.54999995/$5.8499999.
- SRAX Inc. (NASDAQ: SRAX) Ahead of Curve in New California Compliancy Law
- SRAX Inc. (NASDAQ: SRAX) Continues to Empower Customers in the Digital Wave of the Future: Consumer-Managed Data
- SRAX Inc. (NASDAQ: SRAX) Presents at Premier Microcap Investor Conference
Sugarmade, Inc. (SGMD)
Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today announced the closing of its acquisition of BZRTH, LLC, a leading ecommerce supplier to the rapidly expanding hydroponic agricultural space. To view the full press release, visit http://cnw.fm/BV1bn. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how every new report on projected revenues for cannabis, hemp and CBD seem to be larger than the last “newest” report. It has been this way for some time now and it appears that it will continue well into the future… and as the overall global revenues increase it also appears that the growth in one sub-sector may well outpace the growth of all other sectors. Additionally, Financialnewsmedia.com highlighted the company in a report examining how the U.S. and China are opponents in many categories today and years to come. In some of these interactions there are no winners or losers, however, the U.S. is the clear winner in the global hemp cultivation market.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Thursday's trading session at $0.0181, up 24.8276%, on 31,460,188 volume with 972 trades. The average volume for the last 3 months is 5,135,518 and the stock's 52-week low/high is $0.00975/$0.134000003.
- Sugarmade, Inc. (SGMD) Acquires BZRTH, LLC as Part of Roll-Up Strategy to Create Dominant Force in $24B Global Hydroponics Market
- Hydroponics Revenues Set To Become Larger Sector Of Global Cannabis & Hemp Revenues
- U.S. Cannabinoid Market Including Hemp Now Projected to Reach $44.8 billion by 2024
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in a publication from Financialnewsmedia.com. Every new report on projected revenues for cannabis, hemp and CBD seem to be larger than the last “newest” report. It has been this way for some time now and it appears that it will continue well into the future… and as the overall global revenues increase it also appears that the growth in one sub-sector may well outpace the growth of all other sectors. While cannabis/hemp has been experiencing continued growth, so has the global hydroponics market (across all cultivation categories) and the marriage of both the bodes well for the hydroponics market cannabis/hemp sector growth share of the global cannabis/hemp markets.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.5345, off by 2.8182%, on 290,152 volume with 276 trades. The average volume for the last 3 months is 512,956 and the stock's 52-week low/high is $0.479999989/$1.7888.
- Hydroponics Revenues Set To Become Larger Sector Of Global Cannabis & Hemp Revenues
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Departure of Chief Advocacy Officer
- Supreme Cannabis Announces Departure of Chief Advocacy Officer, John Fowler
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
Due to the slower pace of legal market conversion, The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium-certified organic cannabis has announced a new strategic plan as the company works to enhance profitability (http://cnw.fm/ehx8M). TGOD will optimize operating efficiency by deferring excess capacity and expenses. A new construction and operating plan to reduce cash needs has been adopted that is expected to lead towards positive operating cash flow in Q2 2020. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how the U.S. and China are opponents in many categories today and years to come. In some of these interactions there are no winners or losers, however, the U.S. is the clear winner in the global hemp cultivation market.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $0.7599, up 4.0959%, on 1,088,955 volume with 498 trades. The average volume for the last 3 months is 1,032,096 and the stock's 52-week low/high is $0.685999989/$4.38000011.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adjusts Construction Roadmap for Agile Capacity Management
- U.S. Cannabinoid Market Including Hemp Now Projected to Reach $44.8 billion by 2024
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Gives ‘Power to Flower’ in Certified Organic Cultivation Process
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Cannabis and health care product developer Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)is watching its brands grow throughout the North American continent this year and across the ocean during a period of heady advances for the overarching industry.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Thursday's trading session at $0.21788, up 5.4088%, on 1,243 volume with 4 trades. The average volume for the last 3 months is 11,286 and the stock's 52-week low/high is $0.196700006/$0.700999975.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Blooming with Nationwide, International Cannabis Product Distribution Deals
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expanding CBD Market Presence Domestically, Internationally
- As CBD Shines, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Fuels Growth of National and Global Distribution Networks
VPR Brands, LP (VPRB)
VPR Brands, LP (VPRB) was featured today in a publication from CBDWire, examining how young Bailey Rankmore suffers from Lennox-Gastaut syndrome, a particularly nasty form of epilepsy that sees him having up to 100 seizures on a daily basis. He is the latest in an increasing number of people in the UK who have used CBD to help manage severe conditions.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Thursday's trading session at $0.05, up 14.7842%, on 277,683 volume with 21 trades. The average volume for the last 3 months is 133,218 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- Parents of Epileptic Teen Plead For Easier Access to CBD Prescriptions
- VPR Brands LP (VPRB) Among Industry Players Awaiting Final USDA Hemp Rules
- 420 with CNW – Finnish Government to Consider Petition to Decriminalize Marijuana
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
Tacoma, Washington-based cannabis holding company IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) is planning to expand its footprint throughout the United States, and aims to reach at least 318 stores in California and 225 stores in Oregon by January 2020. To view the full article, visit http://cnw.fm/Rqu6D.
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Thursday's trading session at $0.02961, off by 8.8923%, on 212,300 volume with 41 trades. The average volume for the last 3 months is 246,846 and the stock's 52-week low/high is $0.019999999/$0.634559988.
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Sets Sights on National Expansion
- CBD Company Receives Joint Warning Letter from FTC and FDA
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) DTC Eligibility Promotes Convenience, Liquidity for Investors
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Building Backbone for Battle with MMA Development League
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Featured in Broadcast Discussing California’s Cannabis Industry
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Stock Gains on Receipt of New License and Strategic Partnership
- ChineseInvestors.com (CIIX) Subsidiary to Attend Industrial Cannabis Conferences in China
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Brings Micro-Targeting to Brand Distributers, Marketers
- Dama Financial - Provides Access to Transparent Banking Services for Cannabis Industry
- Earth Science Tech, Inc. (ETST) Star Promises to Come Out of Retirement if NFL Okays CBD
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse® Receives Positive Review in Video Testimonial
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference
- GP Solutions (GWPD) Launches Proprietary, Cost-Effective Growth Medium
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Why the Marijuana Black Market May Be Hard to Eradicate for Now
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) CBD is Quickly Becoming the Most Searched Topic on Google
- Green Hygienics Holdings Inc. (OTC: GRYN) to Purchase Office and Warehouse Property in Poway Business Park Near San Diego
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Provides Recent Activities Update
- InsuraGuest Inc. - Inks Contract with Cal-Vegas, Ltd. for Columbia, South Carolina Hotel to Offer Specialized Insurance Coverage
- INmune Bio, Inc. (NASDAQ: INMB) XPro1595 Highlighted During Press Conference at the Society for Neuroscience 49th Annual Meeting
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) CBD Company Receives Joint Warning Letter from FTC and FDA
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Illinois Hemp Farmer Shares Experience of Going Back to Farming Basics
- LiveWire Ergogenics Inc. (OTC: LVVV) CEO Discusses Company’s Evolving Role in Multibillion Cannabis Industry in Exclusive NetworkNewsWire Broadcast
- Marijuana Company of America Inc. (MCOA) North Carolina Senate Reaches Compromise on Hemp Law
- MustGrow Biologics Corp (CSE: MGRO) Biological Solutions for Cannabis Growers
- Neutra Corp. (OTCQB: NTRR) Horizons in Sight: Company Targets New Hemp-Based CBD Products and Markets
- Nightfood, Inc. (OTCQB: NGTF) Hires MSourceIdeas and Industry Expert Lionel Binnie to Develop Distribution Footprint in College Campus and Hospitality Markets
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Illinois Hemp Farmer Shares Experience of Going Back to Farming Basics
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- OriginClear (OCLND) Reports Pilot-Project Win as Proprietary Technology Produces Clear Water from Pig Manure
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Successful Completion of Phase 1 Nickel/Cobalt Process Recovery Program
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Closes Equity Financing, Invests Proceeds in Its Innovative Extraction Technology
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) 420 with CNW – Finnish Government to Consider Petition to Decriminalize Marijuana
- Predictive Oncology Inc. (NASDAQ: POAI) Valuable Database Offers Hope to Cancer Patients of Today and Tomorrow
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Subsidiary Alleges Patent Infringement by Apple Inc.
- Sharing Services Global Corporation (SHRG) Reports Record Revenues, Continues Impressive Sales Momentum
- SinglePoint, Inc. (SING) Gaining Traction with Recent Launch of 1606 Original Hemp
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Report Q3 2019 Financial Results, Host Conference Call
- Spectrum Global Solutions, Inc. (SGSI) Announces Canada Expansion
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Why the Marijuana Black Market May Be Hard to Eradicate for Now
- SRAX Inc. (NASDAQ: SRAX) Continues to Empower Customers in the Digital Wave of the Future: Consumer-Managed Data
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Obtains C$5 Million Convertible Loan Financing
- Sugarmade, Inc. (SGMD) North Carolina Senate Reaches Compromise on Hemp Law
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Departure of Chief Advocacy Officer
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Gives ‘Power to Flower’ in Certified Organic Cultivation Process
- Trxade Group Inc. (TRXD) Acquires Assets of Comprehensive Telemedicine and Telehealth Platform Bonum Health
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Enters Technology and Research Partnership with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF)
- VPR Brands, LP (VPRB) Among Industry Players Awaiting Final USDA Hemp Rules
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expanding CBD Market Presence Domestically, Internationally
- Willow Biosciences Inc. (CSE: WLLW) Iowa Parents Struggle to Find Doctors to Recommend Cannabidiol
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Taking Steps to Increase Production Efficiency, Boost Revenue
- Xalles Holdings Inc. (XALL) Subsidiary Enters Revenue Sharing Agreement with ATN Trading
- Youngevity International, Inc. (NASDAQ: YGYI) Study Finds That CBD Tops Meditation, Marijuana and Exercise in US Google Searches
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.